News archive search
Search the Newsreel
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
- Showing
- 73–108
- Matches
- 268
- Sources here
- 23
- Companies here
- 11
Active search
268 matching headlines
Search results
Matching headlines
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
Dimensional Fund Advisors LP Purchases 138,708 Shares of Diversified Healthcare Trust $DHC
Dimensional Fund Advisors LP increased its stake in Diversified Healthcare Trust (DHC) by 6.1%, purchasing an additional 138,708 shares to now own 2.4 million shares, or 0.99% of the REIT. Institutional investors collectively own 75.98% of DHC, which currently holds a "Moderate Buy" consensus …
Assenagon Asset Management S.A. Buys Shares of 1,540,928 Indivior PLC $INDV
Assenagon Asset Management S.A. has acquired 1,540,928 shares of Indivior PLC (NASDAQ:INDV), representing a 1.26% stake worth approximately $63.2 million. Institutional investors now collectively own 60.33% of the company. Indivior recently reported strong quarterly earnings of $5.75 per share, surpassing full-year analyst expectations, while …
Indivior PLC (INDV) Stock News Today
This page provides news and analysis for Indivior PLC (INDV) stock. It includes current stock price, market capitalization, P/E ratio, and states that more news will be available soon. The platform, TradingKey, offers general information and does not provide financial advice.
Earnings call transcript: Supernus and Indivior post Q2 2026 beat on merger news
Supernus Pharmaceuticals and Indivior Pharmaceuticals announced a Q2 2026 earnings beat and their planned all-stock merger. The combined entity will focus on central nervous system drugs, aiming for $2.2 billion in annual revenue and $125 million in annual cost savings. The merger, expected to …
HC Wainwright Predicts Indivior's Q3 Earnings (NASDAQ:INDV)
HC Wainwright has increased its Q3 2026 EPS estimates for Indivior (NASDAQ:INDV) to $0.93 from $0.78, with forecasts rising through FY2030. Despite a recent price target cut by Barclays, analyst sentiment remains a "Moderate Buy" with an average target of $45.17. Indivior's shares opened …
DIVERSIFIED HEALTHCARE TRUST 6.25% SR NT 01/02/46 USD To Go Ex-Dividend On August 14th, 2026 With 0.39063 USD Dividend Per Share
Diversified Healthcare Trust (NASDAQ: DHC) 6.25% SR NT 01/02/46 USD is scheduled to go ex-dividend on August 14th, 2026. The dividend payment will be 0.39063 USD per share. This information is crucial for investors tracking dividend distributions for this security.
Is Diversified Healthcare Trust (DHC) Fairly Valued After Second Quarter Earnings?
Diversified Healthcare Trust (DHC) is in focus after its Q2 2026 earnings report, showing strong share price momentum and improved net loss figures. Despite this, the stock is considered 7.2% undervalued with a fair value of $9.88 per share, based on expected cash flow …
Global Net Lease Reports Second Quarter 2026 Results
Global Net Lease, Inc. – Reports Q2'26 AFFO Per Share of $0.22;Raises Full-Year AFFO Per Share Guidance to $0.82 – $0.85 and Increases Gross Transaction Volume to $700 Million – $800 Million – Closed Plus Disposition Pipeline Totals $263 Million, with Office Sales Representing …
Diversified Healthcare Trust Encounters Operational ‘Noise’ in Ongoing Portfolio Transitions
Diversified Healthcare Trust (DHC) reported lower-than-expected occupancy and revenue in Q2 2026, which CEO Chris Bilotto attributed to "transition noise" from switching operators for 116 communities. Despite this, the company saw sequential occupancy gains and increased NOI margins, reaffirming its SHOP NOI guidance for …
Indivior Pharmaceuticals, Inc. Quarterly Earnings Report
Indivior Pharmaceuticals, Inc. (INDV) has released its Q2 2026 earnings report, detailing an increase in net revenue driven by strong U.S. sales of SUBLOCADE. The company also announced a proposed all-stock merger with Supernus Pharmaceuticals, Inc., which includes a conditional $1 billion special cash …
Indivior Pharmaceuticals, Inc. (INDV) Stock Analysis: Analyst Consensus Points to 36% Upside Potential
Indivior Pharmaceuticals, Inc. (INDV) is positioned as a key player in opioid dependence treatment, with strong analyst consensus pointing to a 36% upside potential. The company's focus on buprenorphine-based treatments, robust revenue growth of 19.20%, and a product pipeline including SUBLOCADE and SUBOXONE contribute …
$1.8bn merger unites Supernus and Indivior in CNS therapeutics play
Supernus Pharmaceuticals and Indivior Pharmaceutical are merging in an all-stock transaction valued at $1.8 billion, aiming to create a stronger entity in the CNS therapeutics space. The combined company, to be named Supernus, Inc., will leverage commercial and pipeline synergies across neurological and psychiatric …
Diversified Healthcare Trust Q2 Profit Jumps 20% on Senior Housing Strength, Leverage Drops
Diversified Healthcare Trust (DHC) reported strong Q2 results, with consolidated NOI up 20.4% year over year, driven by a significant jump in senior housing operating portfolio (SHOP) NOI and improved occupancy and rates. The company reaffirmed its 2026 guidance for adjusted EBITDARE and normalized …
Earnings call transcript: Diversified Healthcare Trust posts Q2 2026 miss but lifts outlook
Diversified Healthcare Trust (DHC) reported a Q2 2026 loss of $0.16 per share on revenue of $365.39 million, missing analyst expectations. Despite the miss, the company reaffirmed its full-year guidance, driven by strong operating trends, particularly in its senior housing operating properties (SHOP) segment, …
How Investors Are Reacting To Diversified Healthcare Trust (DHC) Narrowing Losses Amid Softer Revenue
Diversified Healthcare Trust (DHC) reported narrower losses in Q2 2026, with a net loss of US$37.42 million despite softer revenue. While this shows progress in reducing financial damage, the company still faces ongoing revenue pressure and high leverage, making refinancing risk a key concern …
Diversified Healthcare (DHC) Q2 FFO Top Estimates
Diversified Healthcare Trust (DHC) reported second-quarter Funds From Operations (FFO) of $0.16 per share, surpassing the Zacks Consensus Estimate of $0.14 per share and significantly higher than $0.08 per share a year ago. Despite missing revenue estimates, the company's FFO surprise was +14.29%, and …
indivior plc. Positive Earnings Pre-Announcements
Indivior plc. (INDV.L, INDV) has pre-announced positive earnings, revising its fiscal year 2026 revenue guidance upwards from an estimated range of $1.215 - $1.285 Billion to $1.295 - $1.365 Billion. This announcement is part of a broader calendar of earnings pre-announcements available through RTTNews. …
Earnings Flash (DHC) Diversified Healthcare Trust Posts Q2 Revenue $365.4 Million, vs. FactSet Est of $370.8 Million
Diversified Healthcare Trust (DHC) reported its second-quarter revenue as $365.4 million, falling short of FactSet's estimate of $370.8 million. This earnings flash provides key financial data for the quarter, highlighting a slight miss on revenue expectations. The article also lists recent news and analyst …
Diversified Healthcare Trust Announces Second Quarter 2026 Results
Diversified Healthcare Trust (DHC) announced its financial results for the second quarter ended June 30, 2026, and provided updated full-year 2026 financial guidance. The company will host a conference call on August 4, 2026, to discuss these results. DHC is a real estate investment …